Esther Dronkers has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Anke M. Smits

    Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands

    5 shared publications
  • Marie-José Goumans

    Department of Cell and Chemical Biology Leiden University Medical Center Leiden The Netherlands

    4 shared publications
  • Doranne Hilarius

    Clinical Audit Board Dutch Medication Audit, Dutch Institute for Clinical Auditing (DICA), Leiden, the Netherlands; Department of Pharmacy, Rode Kruis Ziekenhuis, Beverwijk, the Netherlands

    2 shared publications
  • Esmée van Geffen

    LOGEX Healthcare Analytics, Amsterdam, the Netherlands

    2 shared publications
  • Almira Henic

    Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands

    1 shared publication
  • An Machteld Wymenga

    Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Infant Respiratory Syncytial Virus Hospitalizations Before and After Introduction of Prophylaxis Programs in Spain and the United Kingdom, June 2022–May 2025

    by Oliver Martyn, Rolf Kramer, Karine Mari, Scott A McDonald, Esther Dronkers, Rutger Schim van der Loeff, J Jasper Deuring, Saul N Faust

    Since 2023, Europe has implemented infant respiratory syncytial virus prevention programs. Based on real-world data (2022–2025) from 5 Spanish and 19 UK hospitals, hospitalizations for respiratory syncytial virus–lower respiratory tract infection declined by 55% in Spain (77% in 0–6 months) and 18% in the United Kingdom (31% in 0–6 months), with patterns confirmed by interrupted time series analysis.

  • The effectiveness of pembrolizumab maintenance with or without pemetrexed after induction treatment for advanced non-squamous Non–Small-Cell Lung cancer

    by Bas Jm Peters, Esmée van Geffen, Doranne Hilarius, Stephan Böhringer, Juliëtte Zwaveling, Esther Dronkers, Cor H van der Leest, Hans Jm Smit


  • Open Access

    Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective

    by Geeske F Grit, Esmée van Geffen, Ruben Malmberg, Roelof van Leeuwen, Stefan Böhringer, Hans Jm Smit, Pepijn Brocken, Job Fh Eijsink, Esther Dronkers, Pim Gal, et al.


  • Open Access

    Prrx1b directs pro-regenerative fibroblasts during zebrafish heart regeneration

    by Dennis E.M. de Bakker, Esther Dronkers, Mara Bouwman, Aryan Vink, Marie-José Goumans, Anke M. Smits, Jeroen Bakkers

    Rationale: The human heart loses millions of cardiomyocytes after an ischemic injury, but is unable to regenerate the lost tissue. Instead, the injured human heart is repaired by pro-fibrotic fibroblasts that form a large permanent scar. In contrast, the injured zebrafish heart regenerates efficiently without the formation of a permanent scar. While fibroblasts have been shown to be indispensable for zebrafish heart regeneration, very little is known about the mechanisms balancing the fibrotic and regenerative response. A better understanding of these mechanisms could lead to the discovery of novel therapeutic strategies to reduce fibrosis and promote heart regeneration. Objective: To identify novel mechanisms that regulate the balance between cardiac fibrosis and scar-free regeneration. Methods and Results: Using a genetic approach, we first show that zebrafish prrx1b loss-of-function mutants display reduced cardiomyocyte proliferation and impaired heart regeneration. Using a lineage tracing approach, we show that Prrx1b is expressed in tcf21 + epicardial-derived cells localizing around and inside the injured area. Next, we used a single cell RNA-sequencing approach on sorted tcf21 + cells isolated from injured prrx1b -/- and wild-type hearts and identified two distinct fibroblast populations. With combined bioinformatic and histological analysis we found that prrx1b -/- hearts contain an excess of pro-fibrotic fibroblasts that produce TGF-β ligands and collagens, while fewer pro-regenerative Nrg1-expressing fibroblasts are formed. Furthermore, by injecting recombinant NRG1 in prrx1b -/- fish we were able to rescue their cardiomyocyte proliferation defect. Finally, using cultured human fetal epicardial cells and siRNA mediated knock-down of PRRX1 we found that PRRX1 is required for NRG1 induction in human epicardial-derived cells. Conclusions: Prrx1b in the injured heart restricts fibrosis and stimulates regeneration by directing epicardial-derived cells towards a pro-regenerative Nrg1-producing fibroblast state.

  • Open Access

    Epicardial TGFβ and BMP Signaling in Cardiac Regeneration: What Lesson Can We Learn from the Developing Heart?

    by Esther Dronkers, Manon M. M. Wauters, Marie José Goumans, Anke M. Smits

    The epicardium, the outer layer of the heart, has been of interest in cardiac research due to its vital role in the developing and diseased heart. During development, epicardial cells are active and supply cells and paracrine cues to the myocardium. In the injured adult heart, the epicardium is re-activated and recapitulates embryonic behavior that is essential for a proper repair response. Two indispensable processes for epicardial contribution to heart tissue formation are epithelial to mesenchymal transition (EMT), and tissue invasion. One of the key groups of cytokines regulating both EMT and invasion is the transforming growth factor β (TGFβ) family, including TGFβ and Bone Morphogenetic Protein (BMP). Abundant research has been performed to understand the role of TGFβ family signaling in the developing epicardium. However, less is known about signaling in the adult epicardium. This review provides an overview of the current knowledge on the role of TGFβ in epicardial behavior both in the development and in the repair of the heart. We aim to describe the presence of involved ligands and receptors to establish if and when signaling can occur. Finally, we discuss potential targets to improve the epicardial contribution to cardiac repair as a starting point for future investigation.


  • The Isolation and Culture of Primary Epicardial Cells Derived from Human Adult and Fetal Heart Specimens

    by Esther Dronkers, Asja T. Moerkamp, Tessa van Herwaarden, Marie-José Goumans, Anke M. Smits

    The epicardium, an epithelial cell layer covering the myocardium, has an essential role during cardiac development, as well as in the repair response of the heart after ischemic injury. When activated, epicardial cells undergo a process known as epithelial to mesenchymal transition (EMT) to provide cells to the regenerating myocardium. Furthermore, the epicardium contributes via secretion of essential paracrine factors. To fully appreciate the regenerative potential of the epicardium, a human cell model is required. Here we outline a novel cell culture model to derive primary epicardial derived cells (EPDCs) from human adult and fetal cardiac tissue. To isolate EPDCs, the epicardium is dissected from the outside of the heart specimen and processed into a single cell suspension. Next, EPDCs are plated and cultured in EPDC medium containing the ALK 5-kinase inhibitor SB431542 to maintain their epithelial phenotype. EMT is induced by stimulation with TGFβ. This method enables, for the first time, the study of the process of human epicardial EMT in a controlled setting, and facilitates gaining more insight in the secretome of EPDCs that may aid heart regeneration. Furthermore, this uniform approach allows for direct comparison of human adult and fetal epicardial behavior.


  • Open Access

    Antibacterial Defense of Human Airway Epithelial Cells from Chronic Obstructive Pulmonary Disease Patients Induced by Acute Exposure to Nontypeable Haemophilus influenzae: Modulation by Cigarette Smoke

    by Gimano D. Amatngalim, Jasmijn A. Schrumpf, Almira Henic, Esther Dronkers, Renate M. Verhoosel, Soledad R. Ordonez, Henk P. Haagsman, Maria E. Fuentes, Sriram Sridhar, Jamil Aarbiou, et al.

    Antimicrobial proteins and peptides (AMPs) are a central component of the antibacterial activity of airway epithelial cells. It has been proposed that a decrease in antibacterial lung defense contributes to an increased susceptibility to microbial infection in smokers and patients with chronic obstructive pulmonary disease (COPD). However, whether reduced AMP expression in the epithelium contributes to this lower defense is largely unknown. We investigated the bacterial killing activity and expression of AMPs by air-liquid interface-cultured primary bronchial epithelial cells from COPD patients and non-COPD (ex-)smokers that were stimulated with nontypeable Haemophilus influenzae (NTHi). In addition, the effect of cigarette smoke on AMP expression and the activation of signaling pathways was determined. COPD cell cultures displayed reduced antibacterial activity, whereas smoke exposure suppressed the NTHi-induced expression of AMPs and further increased IL-8 expression in COPD and non-COPD cultures. Moreover, smoke exposure impaired NTHi-induced activation of NF-κB, but not MAP-kinase signaling. Our findings demonstrate that the antibacterial activity of cultured airway epithelial cells induced by acute bacterial exposure was reduced in COPD and suppressed by cigarette smoke, whereas inflammatory responses persisted. These findings help to explain the imbalance between protective antibacterial and destructive inflammatory innate immune responses in COPD.


  • Open Access

    Human fetal and adult epicardial-derived cells: a novel model to study their activation

    by Asja T. Moerkamp, Kirsten Lodder, Tessa van Herwaarden, Esther Dronkers, Calinda K. E. Dingenouts, Fredrik C. Tengström, Thomas J. van Brakel, Marie-José Goumans, Anke M. Smits

    Background: The epicardium, a cell layer covering the heart, plays an important role during cardiogenesis providing cardiovascular cell types and instructive signals, but becomes quiescent during adulthood. Upon cardiac injury the epicardium is activated, which includes induction of a developmental gene program, epithelial-to-mesenchymal transition (EMT) and migration. However, the response of the adult epicardium is suboptimal compared to the active contribution of the fetal epicardium to heart development. To understand the therapeutic value of epicardial-derived cells (EPDCs), a direct comparison of fetal and adult sources is paramount. Such analysis has been hampered by the lack of appropriate culture systems. Methods: Human fetal and adult EPDCs were isolated from cardiac specimens obtained after informed consent. EPDCs were cultured in the presence of an inhibitor of the TGFβ receptor ALK5. EMT was induced by stimulation with 1 ng/ml TGFβ. PCR, immunofluorescent staining, scratch assay, tube formation assay and RT2-PCR for human EMT genes were performed to functionally characterize and compare fetal and adult EPDCs. Results: In this study, a novel protocol is presented that allows efficient isolation of human EPDCs from fetal and adult heart tissue. In vitro, EPDCs maintain epithelial characteristics and undergo EMT upon TGFβ stimulation. Although similar in several aspects, we observed important differences between fetal and adult EPDCs. Fetal and adult cells display equal migration abilities in their epithelial state. However, while TGFβ stimulation enhanced adult EPDC migration, it resulted in a reduced migration in fetal EPDCs. Matrigel assays revealed the ability of adult EPDCs to form tube-like structures, which was absent in fetal cells. Furthermore, we observed that fetal cells progress through EMT faster and undergo spontaneous EMT when TGFβ signaling is not suppressed, indicating that fetal EPDCs more rapidly respond to environmental changes. Conclusions: Our data suggest that fetal and adult EPDCs are in a different state of activation and that their phenotypic plasticity is determined by this activation state. This culture system allows us to establish the cues that determine epicardial activation, behavior, and plasticity and thereby optimize the adult response post-injury.